Skip to main content
SpringerLink
Log in

Tendon Pathology in Hypercholesterolemia and Familial Hypercholesterolemia

  • Orphan Diseases (B Manger, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Hypercholesterolemia (HC), or high cholesterol, is usually caused by diet, other health conditions, or inherited diseases, such as familial hypercholesterolemia (FHC). Studies have shown patients with hypercholesterolemia are more prone to tendon injury and impaired healing. Nonetheless, the mechanism by which high cholesterol alters the biochemical and biomechanical properties of tendon and the healing environment is not well defined. This review highlights scientific findings on the relationship between hypercholesterolemia and treatments and tendon pathology at the cellular and tissue level.

Recent Findings

The release of pro-inflammatory cytokines and upregulation of matrix-degrading proteins in hypercholesterolemic conditions leads to an increase in tendon stiffness and elastic modulus. The effect of hypercholesterolemia drugs, such as statins, on tendon pathology remains unclear.

Summary

More insight into the relationship between HC and tendon pathology can lead to improved imaging modalities and therapeutics for tendinopathy in hypercholesterolemic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Soslowsky LJ, Fryhofer GW. Tendon homeostasis in hypercholesterolemia. Adv Exp Med Biol. 2016:151–65. This review article thoroughly explores the clinical link between tendon pathology and hypercholesterolemia and familial hypercholesterolemia and discusses the mechanisms by which cholesterol-related changes affect tendon health. The article includes future directions for studies on tendon pathology in hypercholesterolemic conditions.

  2. Carroll MD, Kit BK, Lacher DA, Yoon SS. Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013.

  3. • Klose G, Laufs U, März W, Windler E. Familial hypercholesterolemia: developments in diagnosis and treatment. Dtsch Arztebl Int. 2014;111(31–32):523–9. This is a review article on the recent and pertinent literature on familial hypercholesterolemia. This article includes insight on the prognosis, the diagnostic findings, and traditional and novel treatments for this particular disease.

    PubMed  PubMed Central  Google Scholar 

  4. Marks D, Thorogood M, Neil HAW, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis [Internet]. 2003;168(1):1–14. Available from: http://www.sciencedirect.com/science/article/pii/S0021915002003301

    Article  CAS  Google Scholar 

  5. Goldstein JL BM. Familial Hypercholesterolaemia. Scriver CR et al., editor. New York: McGraw Hill; 1995. 1215–1245 p.

  6. Abifadel M, Varret M, Rabès J-P, Allard D, Ouguerram K, Devillers M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet [internet]. 2003;34(2):154–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12730697

    Article  CAS  Google Scholar 

  7. Goldstein JL, Brown MS. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A [Internet]. 1973;70(10):2804–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=427113&tool=pmcentrez&rendertype=abstract

    Article  CAS  Google Scholar 

  8. Brown MS, Goldstein JL. M58 a receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232(4746):34–47.

    Article  CAS  PubMed  Google Scholar 

  9. Mombelli G, Pavanello C. Novel therapeutic strategies for the homozygous familial hypercholesterolemia. Recent Pat Cardiovasc Drug Discov. 2013;8(2):143–50.

    Article  CAS  PubMed  Google Scholar 

  10. Suzuki T, Okamoto A. Marked multiple tendinitis at the onset of rheumatoid arthritis in a patient with heterozygous familial hypercholesterolemia: ultrasonographic observation. Case Rep Rheumatol [Internet]. 2014;2014:486348. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4070418&tool=pmcentrez&rendertype=abstract

    Google Scholar 

  11. Dagistan E, Canan A, Kizildag B, Barut AY. Multiple tendon xanthomas in patient with heterozygous familial hypercholesterolaemia: sonographic and MRI findings. BMJ Case Rep. 2013:1–3.

  12. Langer T, Strober W, Levy RI. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest. 1972.

  13. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990.

  14. Glueck CJLR. Acute tendinitis and arthritis type II hyperlipoproteinemia. A presenting symptom of familial type II hyperlipoproteinemia. JAMA. 1968;206(13):2895–7.

    Article  CAS  PubMed  Google Scholar 

  15. Kedar E, Gardner GC. Lipid-associated rheumatologic syndromes. Rheum Dis Clin North Am [Internet]. 2013;39(2):481–93. https://doi.org/10.1016/j.rdc.2013.02.014.

    Article  Google Scholar 

  16. Tsouli SG, Kiortsis DN, Argyropoulou MI, Mikhailidis DP, Elisaf MS. Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Invest. 2005;35:236–44.

    Article  CAS  PubMed  Google Scholar 

  17. Mabuchi H, Ito S, Haba T, Ueda KUR. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles’ tendon thickness. Atherosclerosis. 1977;28:61–8.

    Article  CAS  PubMed  Google Scholar 

  18. Myant NBSJ. Type II hyperlipoproteinaemia. Endocrinol Metab. 1973;2:81–109.

    CAS  Google Scholar 

  19. Lakey WC, Greyshock N, Guyton JR. Adverse reactions of Achilles tendon xanthomas in three hypercholesterolemic patients after treatment intensification with niacin and bile acid sequestrants. J Clin Lipidol [Internet]. 2013;7(2):178–81. https://doi.org/10.1016/j.jacl.2012.11.002.

    Article  Google Scholar 

  20. • Nielsen MH, Irvine H, Vedel S, Raungaard B, Beck-Nielsen H, Handberg A. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One. 2015;10(4):1–19. The aim of the work was to investigate the effect of elevated oxidized LDL cholesterol on the release of pro-inflammatory monocytes and monocyte-derived microparticles (MMPs). Blood samples were collected from patients with familial hypercholesterolemia with or without xanthomas and monocytes classification and MMPs analysis was performed by flow cytometry. The conclusions were that lipoprotein-associated oxidative stress was involved in accelerated familial hypercholesterolemia and xanthomas formation.

    Article  Google Scholar 

  21. Riley GP, Curry V, DeGroot J, Van El B, Verzijl N, Hazleman BL, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002;21(2):185–95.

    Article  CAS  PubMed  Google Scholar 

  22. Ronnemaa T, Juva K, Kulonen E. Effect of hyperlipidemic rat serum on the synthesis of collagen by chick embryo fibroblasts. Atherosclerosis. 1975;21(3):315–24.

    Article  CAS  PubMed  Google Scholar 

  23. Abate M, Schiavone C, Salini V, Andia I. Occurrence of tendon pathologies in metabolic disorders. Rheumatol (United Kingdom). 2013;52(4):599–608.

    CAS  Google Scholar 

  24. Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, et al. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 2005;579(20):4503–12.

    Article  CAS  PubMed  Google Scholar 

  25. Parkinson J, Samiric T, Ilic MZ, Cook J, Handley CJ. Involvement of proteoglycans in tendinopathy. J Musculoskelet Neuronal Interact. 2011;11:86–93.

    CAS  PubMed  Google Scholar 

  26. Beason DP, Abboud JA, Kuntz AF, Bassora R, Soslowsky LJ. Cumulative effects of hypercholesterolemia on tendon biomechanics in a mouse model. J Orthop Res. 2011;29(3):380–3.

    Article  PubMed  Google Scholar 

  27. Beason D, Abboud J, Bassora A, Kuntz A SL. Hypercholesterolemia is detrimental to tendon properties and healing in a mouse injury model. Trans Orthop Res Soc. 2009;1418.

  28. Beason DP, Hsu JE, Marshall SM, McDaniel AL, Temel RE, Abboud JA, et al. Hypercholesterolemia increases supraspinatus tendon stiffness and elastic modulus across multiple species. J Shoulder Elb Surg. 2013;22(5):681–6.

    Article  Google Scholar 

  29. Beason D, Kuntz A, Hamamdzic R, Mohler EAJ. High cholesterol adversely affects biceps tendon mechanical properties in a porcine model. Trans Orthop Res Soc. 2009;184.

  30. • Beason DP, Tucker JJ, Lee CS, Edelstein L, Abboud JA, Soslowsky LJ. Rat rotator cuff tendon-to-bone healing properties are adversely affected by hypercholesterolemia. J Shoulder Elb Surg. 2014;23(6):867–72. Clinical data has linked hypercholesterolemia to full-thickness rotator cuff tears and experimental data has shown the effect of high cholesterol on native tendon properties in multiple species. Unilateral supraspinatus detachment and repair surgery was performed on rats with and without high cholesterol and biomechanical testing and histology was performed to determine the cellular and tissue response to hypercholesterolemic conditions. The supraspinatus tendons in the hypercholesterolemic rats were significantly reduced in normalized stiffness at 4 weeks post-injury and there were no significant differences in collagen organization, cell shape, or cellularity between groups.

    Article  Google Scholar 

  31. Chaudhury S, Dines JS, Delos D, Warren RF, Voigt C, Rodeo SA. Role of fatty infiltration in the pathophysiology and outcomes of rotator cuff tears. Arthritis Care Res (Hoboken) [internet]. 2012;64(1):76–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21770040

    Article  Google Scholar 

  32. Abtahi AM. Factors affecting healing after arthroscopic rotator cuff repair. World J Orthop [Internet]. 2015;6(2):211. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4363803&tool=pmcentrez&rendertype=abstract%5Cn, http://www.wjgnet.com/2218-5836/full/v6/i2/211.htm

    Article  Google Scholar 

  33. Abboud JA, Kim JS. The effect of hypercholesterolemia on rotator cuff disease. In: Clinical Orthopaedics and Related Research. 2010. p 1493–7.

  34. De Oliveira LP, Vieira CP, Guerra FDR, de Almeida MS, Pimentel ER. Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology. 2013;311(3):162–8.

    Article  PubMed  Google Scholar 

  35. Tucker JJ, Soslowsky LJ. Effect of simvastatin on rat supraspinatus tendon mechanical and histological properties in a diet-induced hypercholesterolemia model. J Orthop Res. 2016;34(11):2009–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, et al. Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine 2014.

  37. Marie I, Delafenêtre H, Massy N, Thuillez C, Noblet C. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Care Res. 2008.

  38. • Kuzma-Kuzniarska M, Cornell HR, Moneke MC, Carr AJ, Hulley PA. Lovastatin-mediated changes in human tendon cells. J Cell Physiol. 2015;230(10):2543–51. This recent work focuses on the in vitro response of tenocytes to drugs in the statin family. This is the first study to explore tendon-specific effects of statins in human primary tenocytes. The statins used in this study included simvastatin, atorvastatin, and lovastatin. All three drugs reduced cell migration and prolonged exposure to high concentrations of lovastatin-induced changes in cellular cytoskeleton, mRNA levels for matrix proteins, and increased BMP-2 expression.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Savvidou C, Moreno R. Spontaneous distal biceps tendon ruptures: are they related to statin administration? Hand Surg [internet]. 2012;17(2):167–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22745079

    Article  Google Scholar 

  40. Contractor T, Beri A, Gardiner JC, Tang X, Dwamena FC. Is statin use associated with tendon rupture? A population-based retrospective cohort analysis. Am J Ther [Internet]. 2015;22(5):377–81. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84941880893&partnerID=tZOtx3y1

    Article  Google Scholar 

  41. Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. Statins and tendinopathy: a systematic review. Med J Aust. 2016;204(3):115–22.

    Article  PubMed  Google Scholar 

  42. Lin TT-L, Lin C-H, Chang C-L, Chi C-H, Chang S-T, Sheu WH-H. The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: a nationwide, 11-year, longitudinal, population-based follow-up study. Am J Sports Med [Internet]. 2015;43(9):2126–32. Available from: http://ajs.sagepub.com/content/early/2015/06/17/0363546515588173.full

    Article  Google Scholar 

  43. Schweitzer ME, Karasick D. MR imaging of disorders of the Achilles tendon. Am J Roentgenol. 2000;175(3):613–25.

    Article  CAS  Google Scholar 

  44. Michikura M, Ogura M, Yamamoto M, Sekimoto M, Fuke C, Hori M, et al. Achilles tendon ultrasonography for diagnosis of familial hypercholesterolemia among Japanese subjects. Circ J 2017.

  45. Reina D, Jericó C, Estrada P, Navarro V, Torrente V, Armario P, et al. Ecografía en el diagnóstico y manejo de los xantomas tendinosos en la hipercolesterolemia familiar. Reumatol Clínica. 2017.

  46. Abate M, Schiavone C, Salini V, Andia I. Occurrence of tendon pathologies in metabolic disorders. Rheumatology. 2013;52(4):599–608.

    Article  CAS  PubMed  Google Scholar 

  47. Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. 2012.

  48. Kroon AA, van’t Hof MA, Demacker PN, Stalenhoef AF. The rebound of lipoproteins after LDL-apheresis. kinetics and estimation of mean lipoprotein levels. Atherosclerosis. 2000;152(2):519–26.

    Article  CAS  PubMed  Google Scholar 

  49. •• Arca M. Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): the promises of PCSK9 inhibitors. Atherosclerosis. 2017;256:134–45. The monoclonal antibodies against serine protease proprotein convertase subtillisin-kexin type 9 (PCSK9) is new drug that has the potential to reduce lipoprotein cholesterol (LDL-C) levels by 50% - 60% when combined with standard lipid-lowering drugs. This review article highlights the use of this novel treatment for patients with heterozygous familial hypercholesterolemia and defines the positive outcomes.

    Article  CAS  PubMed  Google Scholar 

  50. Vuorio A, Tikkanen MJ, Kovanen PT. Inhibition of hepatic microsomal triglyceride transfer protein—a novel therapeutic option for treatment of homozygous familial hypercholesterolemia. Vasc Health Risk Manag. 2014;10:263–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Wong E, Goldberg T. Mipomersen (kynamro): a novel antisense oligonucleotide inhibitor for the management of homozygous familial hypercholesterolemia. P T. 2014;39(2):119–22.

    PubMed  PubMed Central  Google Scholar 

  52. •• Bea AM, Perez-Calahorra S, Marco-Benedi V, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, et al. Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia. Atherosclerosis. 2017;263:92–6. This is the first study on the effect of lipoprotein cholesterol lowering effects of PCSK9, alirocumab and evolocumab on tendon xanthomas. The concluding results suggest that PCSK9 is efficient in reducing lipid deposits in the tendons of patients with heterozygous familial hypercholesterolemia when used in combination with standard statin treatments.

    Article  CAS  PubMed  Google Scholar 

  53. Weinreich M, Frishman WH. Antihyperlipidemic therapies targeting PCSK9. Cardiol Rev. 2014;22(3):140–6.

    Article  PubMed  Google Scholar 

  54. Moroney PJ, Besse JL. Resection of bilateral massive Achilles tendon xanthomata with reconstruction using a flexor hallucis longus tendon transfer and Bosworth turndown flap: a case report and literature review. Foot Ankle Surg [Internet]. 2012;18(3):e20–3. https://doi.org/10.1016/j.fas.2012.03.004.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. McKay Orthopaedic Laboratory, University of Pennsylvania, Stemmler Hall 36th Street and Hamilton Walk, Philadelphia, PA, 19104, USA

    Brittany Taylor, Adnan Cheema & Louis Soslowsky

Authors
  1. Brittany Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adnan Cheema
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Louis Soslowsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Louis Soslowsky.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Orphan Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, B., Cheema, A. & Soslowsky, L. Tendon Pathology in Hypercholesterolemia and Familial Hypercholesterolemia. Curr Rheumatol Rep 19, 76 (2017). https://doi.org/10.1007/s11926-017-0704-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-017-0704-2

Keywords

Search

Navigation